Public Profile

STRAND

STRAND, officially known as STRAND Life Sciences, is a leading player in the biotechnology industry, headquartered in the United States. Founded in 2009, the company has made significant strides in genomic data analysis and precision medicine, focusing on transforming healthcare through innovative technology. With a strong presence in major operational regions across North America and Europe, STRAND offers unique solutions in genomic analytics, enabling healthcare providers to deliver personalised treatment plans. Their flagship products, including advanced bioinformatics tools, stand out for their ability to integrate complex data sets, enhancing diagnostic accuracy and patient outcomes. Recognised for its contributions to the field, STRAND has established a solid market position, collaborating with various healthcare institutions and research organisations. The company continues to push the boundaries of genomic science, driving advancements that shape the future of personalised medicine.

DitchCarbon Score

How does STRAND's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

STRAND's score of 3 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

STRAND's reported carbon emissions

STRAND, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how STRAND is addressing its carbon footprint or contributing to climate action. The absence of documented reduction initiatives suggests a potential area for improvement in their sustainability strategy. As the industry increasingly prioritises climate commitments, STRAND may benefit from establishing clear targets and reporting on its emissions to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. STRAND's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. STRAND is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

STRAND is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Medical Device Manufacturing

FLIR Commercial Systems, Inc.

US
Medical Device Manufacturing
Updated 3 days ago

Acacium Group

GB
Medical Device Manufacturing
Updated 11 days ago

Granville Pike Packaging

CN
Medical Device Manufacturing
Updated 11 days ago

Lothar Medtec

DE
Medical Device Manufacturing
Updated 11 days ago

Red Element

US
Medical Device Manufacturing
Updated 4 days ago

OPTI Medical Systems, Inc.

US
Medical Device Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers